Dermatofibrosarcoma protuberans of the vulva: Clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature

International Journal of Gynecological Pathology

Volumn 18, Issue 4, 1999, Pages 366-373

  Ghorbani, Rhonda P ^a   Malpica, Anais ^b,c   Ayala, Alberto G ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Dermatofibrosarcoma protuberans; Fibrosarcomatous change; Sarcoma; Vulva

Indexed keywords

CD34 ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CASE REPORT; CELL NUCLEUS; CLINICAL FEATURE; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SPINDLE CELL; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; VULVA TUMOR;

EID: 0032859281     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199910000-00012     Document Type: Article

References (28)

1. Enzinger FM, Weiss SW. Fibrohistiocytic tumors of intermediate malignancy. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors, 3rd ed. St. Louis: Mosby, 1995:325-35.
2. Taylor HB, Helwig EB, Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer 1962;15:717-25.
3. Ding J, Hashimoto H, Enjoji M. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinicopathologic study of nine cases and a comparison with allied tumors. Cancer 1989;64:721-9.
4. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans: a clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 1992;16:921-5.
5. Diaz-Casajo C, Weyers W, Borrego L, Inarrea JB, Borghi S. Dermatofibroma protuberans with fibrosarcomatous areas: a clinicopatholoaic and immunohistochemical study in four cases. Am J Dermatopathol 1997;19:562-7
6. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CDM. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 1998;22:576-87.
7. Davos I, Abell MR. Soft tissue sarcomas of vulva. Gynecol Oncol 1976;4:70-86.
8. Soltan MH. Dermatofibrosarcoma protuberans of the vulva: case report. Br J Obstet Gynaecol 1981;88:203-5.
9. Agress R, Figge DC, Tamimi H, Greer B. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol 1983;16:288-91.
10. Bock JE, Andreasson B, Thorn A, Hoick S. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol 1985;20:129-35.
11. Bamhill DR, Boling R, Nobles W, Crooks L, Burke T. Vulvar dermatofibrosarcoma protuberans. Gynecol Oncol 1988;30:149-52.
12. Wrotnowski U, Cooper PH, Shmookler BM. Fibrosarcomatous change in dermatofibrosarcoma protuberans. Am J Surg Pathol 1988;12:287-93.
13. Leake JF, Buscema J, Cho KR, Currie JL. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol 1991;41:245-9.
14. Panidis D, Rousso D, Achparaki A, Georgiadis H, Vlassis G. Recurrence of dermatofibrosarcoma protuberans of the vulva: a clinical, histological, and ultrastructural study. Eur J Gynaecol Oncol 1993;14:182-6.
15. Aartsen EJ, Albus-Lutter CE. Vulvar sarcoma: clinical implications. Eur J Obstet Gynecol Reprod Biol 1994;56:181-9.
16. Nirenberg A, Ostor AG, Slavin J, Riley CB, Rome RM. Primary vulvar sarcomas. Int J Gynecol Pathol 1995;14:55-62.
17. Alvarez-Canas MC, Mayorga M, Fernandez F, et al. Dermatofibrosarcoma protuberans of the vulva: clinico-pathological, immunohistochemical and flow cytometric study of a case. Acta Obstet Gynecol Scand 1996;75:82-5.
18. Karlen JR, Johnson K, Kashkari S. Dermatofibrosarcoma protuberans of the vulva: a case report. J Reprod Med 1996;41:267-9.
19. Garcia C, Clark RE, Buchanan K. Dermatofibrosarcoma protuberans. Int J Dermatol 1996;35:867-71.
20. Chetty R. Dermatofibrosarcoma protuberans of the vulva. Int J Gynecol Cancer 1997;7:461-5.
21. Soergel TM, Doering DL, O'Connor D. Metastatic dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol 1998;71:320-4.
22. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson D. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995;55:215-220.
23. DiSaia PJ, Rutledge F, Smith JP. Sarcoma of the vulva: report of 12 patients. Obstet Gynecol 1971;38:180-4.
24. Weiss SW, Nickoloff BJ. CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993;17:1039-45.
25. Goldblum JR. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch Pathol Lab Med 1995; 119:238-41.
26. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993;15:429-34.
27. Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol 1993;20:154-8.
28. Cohen PR, Rapin RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa [Letter]. Am J Dermatopathol 1994;16:573-4.